baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Actinium Pharmaceuticals Inc/ US00507W2061 /

2024-05-10 10:10:00 PM	Chg. -0.1700	Volume	Bid12:55:48 AM	Ask12:55:48 AM	High	Low
8.7300USD	-1.91%	196,229 Turnover: 1.36 mill.	8.5500Bid Size: 400	8.7200Ask Size: 1,000	9.0000	8.4000

GlobeNewswire 03-04 Tome Biosciences Forms Science and Technology Advisory Committee

GlobeNewswire 2023-11-06 Adverum Biotechnologies Appoints C. David Nicholson, Ph.D. to its Board of Directors

GlobeNewswire 2023-09-05 Sernova Corporation Announces the Appointment of Cynthia Pussinen as CEO

Newsfile Corp 2021-11-08 Investor Summit Group Provides Update on Upcoming Q4 Virtual Summit

GlobeNewswire 2021-11-05 Investor Summit Group Provides Update on Upcoming Q4 Virtual Summit

GlobeNewswire 2021-02-25 Spark Therapeutics Further Strengthens Technical Expertise with Appointment of Cynthia Pussinen as C...

GlobeNewswire 2020-11-12 77 Public Companies to present at the Virtual Fall Investor Summit on November 16th-18th

GlobeNewswire 2020-02-10 SELLAS Names Dragan Cicic, MD, as Senior Vice President, Clinical Development

GlobeNewswire 2019-04-15 New Research: Key Drivers of Growth for Newmark Group, Moody's, Children's Place, Everbridge, Heska,...

GlobeNewswire 2019-02-15 Consolidated Research: 2019 Summary Expectations for Caesars Entertainment, Gol Linhas Aereas Inteli...

GlobeNewswire 2018-12-26 CytoDyn Names Nitya G. Ray, Ph.D. as Chief Technology Officer

GlobeNewswire 2018-08-07 $9.36 Bn Nuclear Medicine/Radiopharmaceutical Market, 2024

GlobeNewswire 2018-07-30 $9.27 Billion Nuclear Medicine/Radiopharmaceuticals Market, 2024

GlobeNewswire 2018-07-17 Actinium Forms Nuclear Medicine Focused Advisory Board to Facilitate Pipeline Clinical Development a...

GlobeNewswire 2018-07-09 Actinium to Host Webcast on July 10, 2018 to Discuss Actimab-A MRD clinical trial for Minimal Residu...

GlobeNewswire 2018-06-28 Actinium Announces New Clinical Trial to Study Effect of Actimab-A on Minimal Residual Disease in Po...

GlobeNewswire 2018-06-26 Actinium Pharmaceuticals Announces Dosing of 38th Patient and 25 Percent Enrollment in Iomab-B Pivot...

GlobeNewswire 2018-06-25 Actinium Provides Update from Society of Nuclear Medicine and Molecular Imaging Annual Meeting

GlobeNewswire 2018-06-14 Atossa Genetics Appoints Two Additional Prominent Industry Executives to Strategic Advisory Board

GlobeNewswire 2018-06-13 Actinium Pharmaceuticals Announces Treatment of First Patient in Novel Combination Trial of Actimab-...

GlobeNewswire 2018-05-01 Actinium Pharmaceuticals Appoints Dr. Jeffrey Chell, Bone Marrow Transplant Visionary and Chief Exec...

GlobeNewswire 2018-04-18 Actinium Pharmaceuticals Strengthens Targeted Myeloablation Focused Clinical Development Team with N...

GlobeNewswire 2018-04-11 Actinium Pharmaceuticals to Showcase Capabilities of its AWE Technology Platform in Developing Biobe...

GlobeNewswire 2018-03-28 Actinium Pharmaceuticals Announces Collaborative Research Partnership with Astellas Leveraging Actin...

GlobeNewswire 2018-03-15 Actinium Pharmaceuticals to Present at 28th Annual Oppenheimer Healthcare Conference

Actinium Pharmaceuticals Inc/ US00507W2061 /

If you wish to receive reply to your feedback, please provide your email address.